Group 1 - The core project of Jinling Pharmaceutical, which involves the construction of a common production platform for core raw materials and high-end pharmaceutical intermediates, has its completion date postponed from March 2026 to March 2028, a delay of 24 months [1] - The project is expected to utilize a total of 100 million yuan in raised funds, but as of September 30, 2025, only 2.57% of the investment has been made, amounting to 256.99 thousand yuan [1] - The company has raised a total of 750 million yuan through a specific stock issuance, with a net amount of 743 million yuan, of which 144 million yuan is budgeted for the raw material project [1] Group 2 - As of September 30, 2025, the company has a balance of 729 million yuan in raised funds, with 680 million yuan allocated for cash management, indicating an idle rate of over 93% [2] - The company asserts that the delay complies with regulatory requirements and does not harm shareholder interests, yet the slow progress of investment projects and prolonged idle funds have raised market concerns [2]

Core Viewpoint - The operating situation of North Huajin Chemical Industry Co., Ltd. remains severe in the first half of 2025, with a continued decline in revenue and an expanded net loss compared to the previous year [1][2]. Group 1: Financial Performance - In the first half of 2025, the company reported an operating revenue of 20.104 billion yuan, a year-on-year decrease of 5.01% [1][2]. - The net loss attributable to shareholders reached 989 million yuan, with the loss scale increasing by 33.15% year-on-year [1][2]. - Following a peak revenue of 49.062 billion yuan in 2022, both revenue and net profit have been declining since 2023, with a significant loss of 2.795 billion yuan in 2024 [2]. Group 2: Business Operations - North Huajin primarily engages in the production and sale of chemical fertilizers and has expanded into petrochemical products, refining, and ethylene since 2007 [2]. - The company has established a comprehensive refining and chemical integration industry chain, including refining, polyolefins, ABS, and pseudocumene [2]. - The decline in performance is attributed to multiple factors, including insufficient global economic growth, fluctuating international oil prices, and increased domestic production capacity [2]. Group 3: Fund Utilization Issues - The company has approximately 3 billion yuan of raised funds that have remained uninvested since they were received at the end of 2014, indicating a long-term idle status [4][6]. - The funds were initially intended for a project in Inner Mongolia, which was halted due to economic feasibility concerns and lack of stable low-cost raw material supply [4][5]. - The prolonged idleness of these funds has raised concerns about corporate governance and the potential negative impact on shareholder value and company performance [6][7].